skip to content

Cambridge Immunology Network

Latest news

Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital

25 March 2021

A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19. The clinical trial - named HEAL-COVID - also aims to cut the number of patients being readmitted to hospital with complications as a result of having COVID. Read the original article here>

Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable

23 March 2021

UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it. Read the original article here>

Hunting for COVID-19 Variants

22 March 2021

The story behind the UK's world-leading SARS-CoV-2 genomics capability. For years, Professor Sharon Peacock has been using cutting-edge genome sequencing to track outbreaks of infectious diseases and to better understand how pathogens spread and evolve. When SARS-CoV-2 emerged just over a year ago, she knew that her work...